Health Canada has granted approval to Zepbound, making it the first treatment in Canada specifically approved for adults with obesity who have moderate-to-severe obstructive sleep apnea.
The one-a-week medication from Eli Lilly Canada has received approval for use in conjunction with a calorie-restricted diet and increased physical activity for adults with a body mass index of 30 or greater.
